FR940719-0-00023 FR940719-0-00006 This action has been analyzed in accordance with the principles and criteria in Executive Order 12612 and it has been determined that the rule does not have sufficient federalism implications to warrant the preparation of a Federalism Assessment. List of Subjects in 21 CFR 1306 Drug traffic control, Prescriptions. For reasons set out above, 21 CFR 1306 is amended as follows: PART 1306_[AMENDED] 1. The authority citation for Part 1306 continues to read as follows: Authority: 21 U.S.C. 821, 829, 871(b), unless otherwise noted. 2. Section 1306.02 is amended by redesignating the current paragraph (h) as paragraph (i) and adding a new paragraph (h) to read as follows: §1306.02 Definitions. * * * * * (h) The term home infusion pharmacy means a pharmacy which compounds solutions for direct administration to a patient in a private residence, Long Term Care Facility or hospice setting by means of parenteral, intravenous, intramuscular, subcutaneous or intraspinal infusion. * * * * * 3. Section 1306.11 is amended by revising paragraph (a) and by adding new paragraphs (e) and (f) as follows: Controlled Substances Listed in Schedule II §1306.11 Requirement of prescription. (a) A pharmacist may dispense directly a controlled substance in Schedule II, which is prescription drug as determined by the Federal Food, Drug and Cosmetic Act, only pursuant to a written prescription signed by the practitioner, except as provided in paragraph (d) of this section. A prescription for a Schedule II controlled substance may be transmitted by the practitioner or the practitioner's agency to a pharmacy via facsimile equipment, provided the original written, signed prescription is presented to the pharmacist for review prior to the actual dispensing of the controlled substance, except as noted in paragraph (e) or (f) of this section. The original prescription shall be maintained in accordance with §1304.04(h). * * * * * (e) A prescription prepared in accordance with §1306.05 written for a Schedule II narcotic substance to be compounded for the direct administration to a patient by parenteral, intravenous, intramuscular, subcutaneous or intraspinal infusion may be transmitted by the practitioner or the practitioner's agent to the home infusion pharmacy by facsimile. The facsimile serves as the original written prescription for purposes of this paragraph (e) and it shall be maintained in accordance with §1304.04(h). (f) A prescription prepared in accordance with §1304.05 written for Schedule II substance for a resident of a Long Term Care Facility may be transmitted by the practitioner or the practitioner's agent to the dispensing pharmacy by facsimile. The facsimile serves as the original written prescription for purposes of this paragraph (f) and it shall be maintained in accordance with §1304.04(h). * * * * * 4. Section 1306.21 is amended by revising paragraphs (a) and (c) as follows: Controlled Substances Listed in Schedules III and IV §1306.21 Requirement of prescription. (a) A pharmacist may dispense directly a controlled substance listed in Schedule III or IV, which is a prescription drug as determined under the Federal Food, Drug and Cosmetic Act, only pursuant to either a written prescription signed by a practitioner or a facsimile of a written, signed prescription transmitted by the practitioner or the practitioner's agent to the pharmacy or pursuant to an oral prescription made by an individual practitioner and promptly reduced to writing by the pharmacist containing all information required in §1306.05, except for the signature of the practitioner. * * * * * (c) An institutional practitioner may administer or dispense directly (but not prescribe) a controlled substance listed in Schedules III or IV only pursuant to written prescription signed by an individual practitioner, or pursuant to a facsimile of a written prescription or order for medication transmitted by the practitioner or the practitioner's agent to the institutional practitioner-pharmacist, or pursuant to an oral prescription made by an individual practitioner and promptly reduced to writing by the pharmacist (containing all information required in §1306.05 except for the signature of the individual practitioner), or pursuant to an order for medication made by an individual practitioner which is dispensed for immediate administration to the ultimate user, subject to §1306.07. * * * * * 5. Section 1306.31 is amended by revising paragraph (c) as follows: Controlled Substances Listed in Schedule V §1306.31 Requirement of prescription. * * * * * (c) An institutional practitioner may administer or dispense directly (but not prescribe) a controlled substance listed in Schedule V only pursuant to a written prescription signed by an individual practitioner, or pursuant to a facsimile of a written prescription transmitted by the practitioner or the practitioner's agent to the institutional practitioner_pharmacist, or pursuant to an oral prescription made by an individual practitioner and promptly reduced to writing by the pharmacist (containing all information required in §1306.05 except for the signature of the practitioner), or pursuant to an order for medication made by an individual practitioner which is dispensed for immediate administration to the ultimate user, subject to §1306.07. Dated: May 10, 1994. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 94&hyph;12173 Filed 5&hyph;18&hyph;94; 8:45 am] BILLING CODE 4410&hyph;09&hyph;M
